Nvidia CEO: E.I. Will Be as Common as Cars Today
E.I. isn't science fiction anymore. It's already here. And one little-known company is quietly supplying the systems behind it. This stock is still under Wall Street's radar... but not for long. You'll get the name, the ticker, and the full thesis inside.
Shares Stats
| Shares Outstanding | 1,767,350,000 |
| Shares Float | 1,765,010,000 |
| Shares Short | 18,080,000 |
| Insider Holdings | 10% |
| Institution Holdings | 74.73% |
About Abbvie Inc
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
General
| Name | Abbvie Inc |
| Ticker | ABBV |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 55,000 |
Highlights
| Analyst Target | 243.64 |
| Market Cap | 387,654,300,000 |
| PE Ratio | 165.50 |
| PEG Ratio | 0.43 |
| EBITDA | 29,518,999,552 |
Financials
| Curr Year EPS Estimate | 10.64 |
| Next Quarter EPS Estimate | 3.34 |
| Profit Margin | 3.94% |
| Operating Margin | 31.95 |
| Return on Assets | 0.10 |
| Return on Equity | 1.38 |
| Revenue | 59.6B |
| Earnings Per Share | 1.31 |
| Revenue Per Share | 33.72 |
| Gross Profit | 42,622,001,152 |
| Quarterly Revenue Growth | 0.09 |
Valuation
| Trailing PE | 167.30 |
| Forward PE | 16.84 |
| Price/Sales (Trailing 12 Mt.) | 6.49 |
| Price/Book (Most Recent Quarter) | 50.46 |
Dividend
Abbvie Inc pays out a dividend of $6.54 per share, with a dividend yield of 2.98%.
ABBV's next dividend payment will be made to shareholders on February 17, 2026.
They pay out 263.15% of their earnings out as a dividend.
Recent Dividends
| Feb 17, 2026 | $1.73 |
| Nov 14, 2025 | $1.64 |
| Aug 15, 2025 | $1.64 |
| May 15, 2025 | $1.64 |
| Feb 14, 2025 | $1.64 |
| Nov 15, 2024 | $1.55 |
| Aug 15, 2024 | $1.55 |
| May 15, 2024 | $1.55 |
| Feb 15, 2024 | $1.55 |
What's Going On With Galaxy Digital Stock Monday?
Galaxy is in the spotlight Monday ahead of third quarter earnings on Tuesday before the market opens.
2026 COLA Increase: Social Security Benefits To Rise By 2.8% In 2026, Here's How Much More You Will Get Every Month
The Social Security Administration announced a 2.8% COLA increase for 2026, affecting 75 million Americans.
A New Weapon in the War on Cancer-And a Rare Opportunity - Ad
This small biotech's patented platform may transform how cancer is treated-boosting performance while reducing toxicity. The science is real, the timing is right, and Big Pharma is already watching.
Wall Street Enters Its Strongest Month: These 7 Stocks Often Crush It
November is historically Wall Street's strongest month. These 7 stocks often delivered standout gains in recent decades.
Trump's White House Bathroom Renovation Sparks Fury, Economist Slams 'Clearly Wrong' Inflation Data And More: This Week In Economy
Week economy roundup: From inflation debates and White House renovations to job declines, stock surges, and Fed rate cuts.
After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad
For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.
Scott Bessent Says No 'Formal Proposal' Yet From Trump On Plan To Scrap Obamacare As President Pushes For Direct Payments
No formal proposal for Obamacare replacement plan seen by Treasury Secretary Bessent, despite Trump's call to redirect funds to Americans.
2,000 mink released from Iowa farm in what trade group calls 'terrorist act'
One or more intruders broke into an Iowa mink farm and released 2,000 of the furbearing animals in what a trade group called a “terrorist act” under federal law.
Forget Amazon's 1997 IPO... This Could Be 287 Times Bigger - Ad
Since Amazon's IPO in 1997, it climbed enough to turn $100 into $250,000. Now, one man says Elon Musk could be gearing up to take his internet satellite giant public... in what Fortune magazine says will be the biggest IPO in history! James Altucher is sharing how ANYONE can get a pre-IPO stake... with as little as $100!
A deal to end the government shutdown is on track but faces hurdles
WASHINGTON (AP) — A legislative package to end appears on track Monday after a handful of Senate Democrats joined with Republicans to break the impasse in what has become of federal , the longest in history.
Republicans Join Democrats To End Trump's Brazil Tariffs Amid Soaring Coffee, Beef Prices, Elizabeth Warren Calls Levies 'Chaotic'
The U.S. Senate passed legislation on Tuesday, overturning President Donald Trump's tariffs on Brazil by terminating the national emergency declared in July to justify the move.
[Revealed] The $100 Starlink Pre-IPO Blueprint! - Ad
Fortune reports Starlink's rumored IPO is set to be the single largest IPO in history. James Altucher has uncovered a way to get a pre-IPO stake BEFORE Starlink goes public. All it takes is just a few minutes of time and as little as $100 to get started.
Why D-Wave Quantum (QBTS) Stock Is Getting Hammered Today
Shares of D-Wave Quantum are trading lower Wednesday afternoon, caught in a broader market downturn.
Texas Instruments Stock Is Tumbling Today: Here's Why
Texas Instruments shares are trading lower on Wednesday after the company issued fourth-quarter earnings and revenue guidance below analyst estimates.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Cathie Wood Bets $21 Million On Robinhood, Snaps Up Netflix — Sells These Two Hot AI Stocks
Ark Invest made significant trades involving Robinhood, Netflix, AMD, and Palantir. These trades reflect Ark's strategic positioning amidst market indicators and corporate developments.
Denny's to be acquired and taken private in a deal valued at $620 million
Denny's said Monday that it's being acquired by a group on investors in a deal that will take the breakfast chain private.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
Why Is Phio Pharmaceuticals Stock Soaring Today?
Shares of Phio Pharmaceuticals Corp. (NASDAQ: PHIO) are rising Monday after the company provided an update on an ongoing medical trial.
France threatens to block Shein over sale of childlike sex dolls ahead of Paris store opening
PARIS (AP) — French authorities have warned they may block access to after it emerged that the online fast fashion giant had been selling sex dolls with a childlike appearance.
A Patented Platform Built for Scale-Early Investors Are Taking Notice - Ad
Backed by seven U.S. patents, this biotech's breakthrough aims to improve the delivery of existing and future cancer drugs-unlocking multiple licensing and revenue paths along the way.
Obesity, diabetes treatments fuel Eli Lilly growth and spark bidding war
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.
Cathie Wood Loads Up On This Tesla Rival As Elon Musk's EV Giant Gears Up For Q3 Earnings
Cathie Wood-led Ark Invest buys shares of BYD Co Ltd despite recent setbacks, showing continued belief in long-term potential in EV market
Jensen Huang's Secret Masterplan Revealed - Ad
NVIDIA's revolutionary new invention just solved the #1 chokepoint that's been strangling big AI companies. And Tech legend Jeff Brown - the Silicon Valley insider who called NVIDIA before it skyrocketed more than 30,000%... says a shocking announcement by NVIDIA CEO Jensen Huang could make a lot of early investors rich.
Trump Calls Stalled Russia-Ukraine Peace Talks 'Very Disappointing,' Cites Success In Azerbaijan-Armenia Deal
Trump frustrated by lack of progress in Russia-Ukraine war, cancels Putin meeting. Defends past success in Azerbaijan-Armenia peace.
Warren Buffett Opens Up About The Biggest Investing Blunders Of His Career — Here They Are
Over the decades, the "Oracle of Omaha" has shared candid reflections on his biggest blunders, from emotional decisions to missed opportunities, all of which provide timeless investing insights.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.
Japan's exports and imports grow in September despite Trump's tariffs
TOKYO (AP) — Japan’s exports grew 4.2% in September, according to government data Wednesday, on robust shipments to Asia that offset a decline in exports to the U.S., which were impacted by President Donald Trump’s tariffs.
Why Is Rein Therapeutics Stock Trading Higher On Monday?
Rein Therapeutics shares rise after the FDA lifts clinical hold on its Phase 2 RENEW trial for idiopathic pulmonary fibrosis treatment LTI-03.
Nvidia CEO: E.I. Will Be as Common as Cars Today - Ad
E.I. isn't science fiction anymore. It's already here. And one little-known company is quietly supplying the systems behind it. This stock is still under Wall Street's radar... but not for long. You'll get the name, the ticker, and the full thesis inside.
Warner Bros., Ford, General Motors Are Among the Top 10 Large-Cap Gainers Last Week (Oct. 20-Oct. 24): Are the Others in Your Portfolio?
Top large-cap gainers last week include SNDK, CRS, PEGA, ISRG, GM, HAL, FIX, WBD, LVS, F on earnings, upgrades, auctions.
China's Gold Binge May Eclipse US Dollar, Says Top Economist
China has emerged as a major force behind the recent surge in gold prices, with its growing influence projected to surpass even that of the U.S. dollar, according to a top economist.
A New Weapon in the War on Cancer-And a Rare Opportunity - Ad
This small biotech's patented platform may transform how cancer is treated-boosting performance while reducing toxicity. The science is real, the timing is right, and Big Pharma is already watching.
Mining giant Anglo American faces class action appeal over alleged lead poisoning in Zambia
CAPE TOWN, South Africa (AP) — An appeal hearing opened Monday in South Africa on whether a subsidiary of British-based mining company was responsible for lead poisoning over decades that affected around 140,000 people in .
USDA is reopening some 2,100 offices to help farmers access $3B in aid despite the ongoing shutdown
The Agriculture Department will reopen about 2,100 county offices all across the country Thursday despite the to help farmers and ranchers get access to $3 billion of aid from existing programs.
After 50 Years of Chemo, One Biotech Could Lead the Next Cancer Breakthrough - Ad
For decades, toxic chemotherapy defined cancer care. This biotech's innovative approach could finally change that. With early results showing precision without poison, this story is one investors will want to see early.
Elizabeth Warren Blasts Amazon For Internet Meltdown, Says 'If A Company Can Break The Entire Internet, They Are Too Big'
Sen. Elizabeth Warren renewed her call to break up Big Tech after a massive Amazon Web Services outage disrupted major global platforms, saying, "If a company can break the entire internet, they are too big."
Bitcoin's Bull Run Is Now At The Fed's Mercy: Here's What That Means
Liquidity shifts from the Federal Reserve could determine whether Bitcoin (CRYPTO: BTC) reverses its downtrend or enters a 2019-style correction.
Forget Amazon's 1997 IPO... This Could Be 287 Times Bigger - Ad
Since Amazon's IPO in 1997, it climbed enough to turn $100 into $250,000. Now, one man says Elon Musk could be gearing up to take his internet satellite giant public... in what Fortune magazine says will be the biggest IPO in history! James Altucher is sharing how ANYONE can get a pre-IPO stake... with as little as $100!
Dogecoin's $0.21 Problem: Why This Analyst Says Keep It On Your Radar
On Monday, social media influencer Ali Martinez, known popularly on X as Ali, drew the attention of the crypto community to an important resistance level for Dogecoin (CRYPTO: DOGE).
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.